Acorda Therapeutics Exploring a Potential Sale
Biotechnology company Acorda Therapeutics is exploring a potential sale, according to people familiar with the matter.
Boeing Tries to Overcome Brazil's Resistance to Embraer Takeover
Boeing is in talks with Embraer and Brazil's government on ways to address concerns about the U.S. planemaker's potential takeover of its Brazilian rival.
Morgan Stanley, Deutsche Bank Detail Tax-Law Charges
Two more big banks said Friday they expect to take significant charges against their fourth-quarter earnings because of the impact of the new U.S. tax-overhaul law.
Tim Cook Stumbles at His Specialty, Shipping Apple Products on Time
Under CEO Tim Cook, Apple has been late shipping new devices, delayed by factors including a large and growing global customer base, and more sophisticated technology.
Wells Fargo Earns New Ire from Bank Overseers
Banking regulators in mid-2017 downgraded one part of a secret assessment of Wells Fargo's health and strength, according to people familiar with the decision.
Last month's report shows delivery companies added 2,100 workers as the warehouse sector lost 4,800 jobs
Ripple Steals Bitcoin's Thunder, Surges 1,184% in a Month
The digital currency offered by the San Francisco startup Ripple has soared 1,184% in the past month, becoming the second-largest crypto-asset. While such moves by virtual currencies have become almost normal, Ripple's move is surprising because of its differences with bitcoin.
Corona Distributor: Legal Weed in California a 'Nonevent' For Beer Sales
Constellation Brands Inc. isn't worried beer sales will slow down in California now that recreational cannabis is legal, even as the Corona distributor develops cannabis-infused drinks that could launch in Canada by 2019.
Businesses Rush to Contain Fallout From Major Chip Flaws
Businesses and institutions raced to patch computer systems as they tried to gauge the fallout from the disclosure this week of two, long-hidden vulnerabilities affecting chips running most of the world's computers.
Why the U.S. Suspects Kaspersky's Software Is a Russian Spy Tool
U.S. officials haven't offered conclusive evidence that antivirus products made by Kaspersky Lab were behind national-security breaches, but a series of incidents drove them to raise alarms about the Russian security-software company.